Abbott Laboratories (ABT)

82.05
0.17 0.21
NYSE : Health Technology
Prev Close 82.22
Open 82.39
Day Low/High 81.67 / 82.58
52 Wk Low/High 60.32 / 82.86
Volume 4.04M
Avg Volume 5.28M
Exchange NYSE
Shares Outstanding 1.76B
Market Cap 145.17B
EPS 1.30
P/E Ratio 55.98
Div & Yield 1.28 (1.46%)
Stay Long Abbott Labs' Investors

Stay Long Abbott Labs' Investors

ABT has been in a strong and durable uptrend and that is likely to continue.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

There Is Good and a Lot of Bad in General Electric Earnings

There Is Good and a Lot of Bad in General Electric Earnings

John Flannery sees progress being made on GE's initiatives, but that is what I expected him to say.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Cramer: How to Find the Open Receiver in a Pullback

Cramer: How to Find the Open Receiver in a Pullback

You've got to run the stock checkdown.

My Rx: Keep Holding Abbott Labs Longs

My Rx: Keep Holding Abbott Labs Longs

The drugmaker is in an uptrend with a price target of $60.

Cramer: What's Tax Reform Got to Do With It?

Cramer: What's Tax Reform Got to Do With It?

Treasury secretary says it's baked into the market, but is anyone really counting on it?

Jim Cramer on Tax Reform, Kellogg, Hain Celestial, Facebook and Western Digital

Jim Cramer on Tax Reform, Kellogg, Hain Celestial, Facebook and Western Digital

Jim Cramer weighs in on the trending news of the day from the floor of the New York Stock Exchange.

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer explains why his Action Alerts Plus charitable portfolio is hanging on to Abbott Laboratories.

Abbott Laboratories Is Still Rising

Abbott Laboratories Is Still Rising

Stay long, and consider raising sell-stop protection to a close below $50.

The Best Companies for Women

The Best Companies for Women

Working Mother and the National Association of Female Executives surveyed companies and found the best ones that do right by women. Find out who you should be working for.

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win

EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.

Cramer: Rotations Hit Companies That Don't Deserve It

Cramer: Rotations Hit Companies That Don't Deserve It

Case in point: Home Depot and Lowe's.

Abbott Laboratories Is Set for Another Breakout

Abbott Laboratories Is Set for Another Breakout

Look to buy at the current market level.

Cramer: You Can't Bet Against the Bonds

Cramer: You Can't Bet Against the Bonds

A rotation that started as the minor chord of the rotational symphony and is now the major one.

Abbott Laboratories Saw a Recent Breakout

Abbott Laboratories Saw a Recent Breakout

Barring a close below $46, we are likely to see ABT remain firm and work higher.

Cramer: You Need 2 Monday Morning Game Plans

Cramer: You Need 2 Monday Morning Game Plans

We really want to shake out the weak hands here.

With Mother's Day Coming Up: Who Are the Best Employers for Working Moms?

With Mother's Day Coming Up: Who Are the Best Employers for Working Moms?

Female representation among the top 10% of earners at the NAFE top companies increased 2% to 41%, the highest since 2013.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

Midday Report: Morgan Stanley Boosts Financials; IBM Drags Dow Into Red

Midday Report: Morgan Stanley Boosts Financials; IBM Drags Dow Into Red

Earnings take center stage again with a disappointment from IBM and a better-than-expected performance from Morgan Stanley dividing markets.

Stocks That Are Changing Direction

Stocks That Are Changing Direction

These charts are showing bullish or bearish reversals.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Abbott Labs Is Set to Go Substantially Higher

Abbott Labs Is Set to Go Substantially Higher

Here are the levels to watch and act on.

Abbott Labs downgraded at BMO

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.